Today in Science
SEE OTHER BRANDS

Fresh science news from the world

Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on June 6, 2025

Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer

Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer

– This submission is supported by the pivotal Phase 3 VERITAC-2 clinical trial, results of which were recently presented at the 2025 American Society for Clinical Oncology Annual Meeting and published in The New England Journal of Medicine – – VERITAC-2 …

BioCryst Achieves Reimbursement for ORLADEYO Across all Major European Countries

BioCryst Achieves Reimbursement for ORLADEYO Across all Major European Countries

RESEARCH TRIANGLE PARK, N.C., June 06, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that, following a positive recommendation from the Zorginstituut Nederland, ORLADEYO® (berotralstat) has been approved for the …

At Neudata Summit, MoonFox Data Presents AI + Alternative Data Solutions, Empowering Global Institutions to Decode China's Market

At Neudata Summit, MoonFox Data Presents AI + Alternative Data Solutions, Empowering Global Institutions to Decode China's Market

SHENZHEN, China, June 06, 2025 (GLOBE NEWSWIRE) -- MoonFox Data, China’s leading provider of all-scenario data insights and analytics services, was recently invited to deliver a keynote address at the Neudata Hong Kong Data Summit 2025, held at the Hong …

Denovo Biopharma Announces Formation of Neuroscience Scientific Advisory Board to Advance Precision Medicine in Depression

Denovo Biopharma Announces Formation of Neuroscience Scientific Advisory Board to Advance Precision Medicine in Depression

- Scientific Advisory Board brings together distinguished experts in neuroscience to support Denovo’s CNS development programs, including the Phase 3-ready lead program, biomarker-guided DB104 (liafensine) in treatment-resistant depression (TRD) - SAN …

Nurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congress (EHA2025)

Nurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congress (EHA2025)

SAN FRANCISCO, June 06, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today announced that …

Air Cargo Market Size to Approach USD 210.93 Billion by 2031, Growing at 5.8% CAGR, Experiences Growth in Adoption of E-Commerce Platforms | The Insight Partners

Air Cargo Market Size to Approach USD 210.93 Billion by 2031, Growing at 5.8% CAGR, Experiences Growth in Adoption of E-Commerce Platforms | The Insight Partners

US …

Lucinity Appoints Payoneer CCO and Goldman Sachs MD as Strategic Advisors

Lucinity Appoints Payoneer CCO and Goldman Sachs MD as Strategic Advisors

REYKJAVIK, Iceland, June 06, 2025 (GLOBE NEWSWIRE) -- Lucinity has expanded its Advisory Council with the appointment of industry leaders Micheal Sheehy, Chief Compliance Officer at Payoneer, and Konstantinos Rizakos, Managing Director of Compliance …

Rectify Pharma Presents Translational Data Demonstrating Improvements in Kidney Function and Reductions in Vascular Calcification at ERA 2025

Rectify Pharma Presents Translational Data Demonstrating Improvements in Kidney Function and Reductions in Vascular Calcification at ERA 2025

Potent, selective ABCC6-targeting positive functional modulator (PFM) improved multiple markers of renal function in animal models of chronic kidney disease (CKD) PFM improved inorganic pyrophosphate (PPi) efflux via on-target engagement of the ABCC6 …

Polpharma Group soutient l’action urgente de l’UE visant à garantir l’accès aux médicaments et à renforcer la souveraineté pharmaceutique européenne

Polpharma Group soutient l’action urgente de l’UE visant à garantir l’accès aux médicaments et à renforcer la souveraineté pharmaceutique européenne

AMSTERDAM, 06 juin 2025 (GLOBE NEWSWIRE) -- Polpharma Group, fabricant européen de produits pharmaceutiques de premier plan, s’est joint aux autres membres de l’association Medicines for Europe pour signer une lettre ouverte adressée aux Premiers ministres …

Die Polpharma Group unterstützt dringende Maßnahmen der EU zur Sicherung des Zugangs zu Arzneimitteln und zur Stärkung der pharmazeutischen Souveränität Europas

Die Polpharma Group unterstützt dringende Maßnahmen der EU zur Sicherung des Zugangs zu Arzneimitteln und zur Stärkung der pharmazeutischen Souveränität Europas

AMSTERDAM, June 06, 2025 (GLOBE NEWSWIRE) -- Die Polpharma Group, ein führender europäischer Pharmahersteller, hat sich anderen Mitgliedern von Medicines for Europe angeschlossen und einen offenen Brief an die Premierminister und Gesundheitsminister aller …

クラウデラ (Cloudera)、AI-RANアライアンスに加盟し、リアルタイムデータの革新とAIネイティブな通信分野の発展を推進

クラウデラ (Cloudera)、AI-RANアライアンスに加盟し、リアルタイムデータの革新とAIネイティブな通信分野の発展を推進

カリフォルニア州サンタクララ発, June 06, 2025 (GLOBE NEWSWIRE) -- データ、分析、AIのための唯一の真のハイブリッドプラットフォームであるクラウデラは本日、AIを通信インフラに統合することを目的とした国際的なコンソーシアムであるAI-RANアライアンスに加盟したことを発表した。 クラウデラは、AI-RANの推進と、通信ネットワークをリアルタイムデータとAIによって知能化された収益創出型プラットフォームへと変革することを目的に、データとAI …

Cloudera, 실시간 데이터 혁신 및 AI 네이티브 통신 추진을 위해 AI-RAN Alliance에 합류

Cloudera, 실시간 데이터 혁신 및 AI 네이티브 통신 추진을 위해 AI-RAN Alliance에 합류

산타클라라, 캘리포니아, June 06, 2025 (GLOBE NEWSWIRE) -- 데이터, 애널리틱스, AI 활용을 위한 하이브리드 유일 플랫폼 Cloudera가 통신 인프라에 AI 통합을 추진 중인 글로벌 컨소시엄인 AI-RAN Alliance에 가입했다고 오늘 발표했다. Cloudera는 AI-RAN 어젠다를 추진하는 한편 통신 네트워크를 실시간 데이터와 AI를 통해 지능형 수익 창출 플랫폼으로 전환하는 데 주력하는 데이터 및 AI 관련 기업들과 …

Cloudera Menyertai AI-RAN Alliance untuk Mendorong Inovasi Data Masa Nyata dan Telekomunikasi Berasaskan AI

Cloudera Menyertai AI-RAN Alliance untuk Mendorong Inovasi Data Masa Nyata dan Telekomunikasi Berasaskan AI

SANTA CLARA, California, June 06, 2025 (GLOBE NEWSWIRE) -- Cloudera, satu-satunya platform hibrid sebenar untuk data, analitik dan AI, hari ini mengumumkan penyertaannya dalam AI-RAN Alliance, sebuah konsortium global yang komited untuk mengintegrasikan AI …

Cloudera 加入 AI-RAN Alliance,驱动实时数据创新与 AI 原生通信

Cloudera 加入 AI-RAN Alliance,驱动实时数据创新与 AI 原生通信

圣克拉拉,加利福尼亚州, June 06, 2025 (GLOBE NEWSWIRE) -- 唯一真正的数据、分析和 AI 混合平台 Cloudera 今日宣布其已加入致力于将 AI 融入电信基础设施的全球联盟 AI-RAN Alliance。 Cloudera 将成为这一开创性创新电信服务商团队中的一员,与数据及 AI 企业共同致力于推动 AI-RAN 议程,通过实时数据与 AI 将电信网络转型为智能创收平台。 随着电信服务商竞相利用虚拟化以及下一代基础设施和架构优化网络运营成本,AI …

Cloudera 加入 AI-RAN 聯盟推動實時數據創新和 AI 原生電訊

Cloudera 加入 AI-RAN 聯盟推動實時數據創新和 AI 原生電訊

聖塔克拉拉,加州, June 06, 2025 (GLOBE NEWSWIRE) -- 唯一真正混合數據、分析和人工智能 (AI) 的平台 Cloudera,於今天宣佈已加入 AI-RAN Alliance;AI-RAN Alliance 是一個全球性聯盟,致力於將 AI 整合到電訊基礎設施中。 Cloudera 與一群開創性的創新電訊提供商,與數據和 AI 公司攜手合作,專注於推動 AI-RAN 目標,將電訊網絡轉換為利用實時數據和 AI 的智能化、產生收入的平台。 …

Huize Holding Limited Reports First Quarter 2025 Unaudited Financial Results

Huize Holding Limited Reports First Quarter 2025 Unaudited Financial Results

SHENZHEN, China, June 06, 2025 (GLOBE NEWSWIRE) -- Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading insurance technology platform connecting consumers, insurance carriers and distribution partners digitally through data- …

QuantaSing Announces Unaudited Financial Results for the Third Quarter of Fiscal Year 2025

QuantaSing Announces Unaudited Financial Results for the Third Quarter of Fiscal Year 2025

BEIJING, June 06, 2025 (GLOBE NEWSWIRE) -- QuantaSing Group Limited (NASDAQ: QSG) (“QuantaSing” or the “Company”), a leading lifestyle solution provider, today announced its unaudited financial results for the third quarter of the fiscal year ending June …

Vesting and settlement of 2022 Conditional Share Awards and Notification of transactions by persons discharging managerial responsibilities

Vesting and settlement of 2022 Conditional Share Awards and Notification of transactions by persons discharging managerial responsibilities

Vesting and settlement of 2022 Conditional Share Awards and Notification of transactions by persons discharging managerial responsibilities Serabi announces that on 5 June 2025 the Board of Directors approved the vesting of Conditional Share Awards that …

Burning Rock Reports First Quarter 2025 Financial Results

Burning Rock Reports First Quarter 2025 Financial Results

GUANGZHOU, China, June 06, 2025 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today …

OBI Pharma Enters ADC Collaboration with TegMine Therapeutics utilizing GlycOBI® and TegMiner™ Enabling Technologies

OBI Pharma Enters ADC Collaboration with TegMine Therapeutics utilizing GlycOBI® and TegMiner™ Enabling Technologies

TAIPEI, Taiwan, June 06, 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (OBI), a clinical-stage global oncology company specialized in the development of novel cancer therapies such as antibody-drug conjugates (ADCs) (4174. TWO), and TegMine Therapeutics, Inc. …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service